echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Signal Transduct Target Ther: How safe are human umbilical cord mesenchymal stem cells to treat COVID-19 patients?

    Signal Transduct Target Ther: How safe are human umbilical cord mesenchymal stem cells to treat COVID-19 patients?

    • Last Update: 2021-06-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    For COVID-19 , there is currently no effective drug treatment
    .


    Host-directed therapies for potentially abnormal immune responses that cause lung tissue damage, death, or long-term dysfunction in survivors require further clinical evaluation


    COVID-19 immune stem cells

    The study recruited 18 hospitalized COVID-19 patients (n = 9 in each group)
    .


    The treatment group received three cycles of intravenous infusion of UC-MSCs (3×107 cells per infusion) on days 0, 3, and 6


     

    No serious adverse events related to the infusion of UC-MSCs were observed during the study
    .


    Two patients who received UC-MSCs developed transient facial flushing and fever, and one patient developed transient hypoxia 12 hours after UC-MSCs infusion


    In summary, the data of the study shows that intravenous infusion of UC-MSCs in patients with moderate to severe COVID-19 is safe and well tolerated
    .


    A phase 2/3 randomized, controlled, double-blind trial with long-term follow-up is needed to evaluate the therapeutic use of UC-MSCs to reduce deaths and improve the long-term treatment effect of patients with severe COVID-19


     

    Original source:

     

    Fanping Meng, Ruonan Xu, et al.


    Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.